Literature DB >> 28765410

Hypertension - state of the art 2017.

Linsay McCallum1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28765410      PMCID： PMC6297669          DOI： 10.7861/clinmedicine.17-4-338

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  20 in total

1.  Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure.

Authors:  Giuseppe Mancia; Rita Facchetti; Michele Bombelli; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2006-03-27       Impact factor: 10.190

2.  Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.

Authors:  James J Oliver; Victoria E C Hughes; James W Dear; David J Webb
Journal:  Hypertension       Date:  2010-05-17       Impact factor: 10.190

Review 3.  Antihypertensive treatment and the J-curve.

Authors:  J M Cruickshank
Journal:  Cardiovasc Drugs Ther       Date:  2000-08       Impact factor: 3.727

4.  Medicine. The genetics of primary aldosteronism.

Authors:  John W Funder
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

5.  Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.

Authors:  Feng J He; Graham A MacGregor
Journal:  Lancet       Date:  2011-07-30       Impact factor: 79.321

6.  Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial.

Authors:  Richard J McManus; Jonathan Mant; Emma P Bray; Roger Holder; Miren I Jones; Sheila Greenfield; Billingsley Kaambwa; Miriam Banting; Stirling Bryan; Paul Little; Bryan Williams; F D Richard Hobbs
Journal:  Lancet       Date:  2010-07-08       Impact factor: 79.321

7.  Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Authors:  Donald E Kohan; Yili Pritchett; Mark Molitch; Shihua Wen; Tushar Garimella; Paul Audhya; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 10.121

8.  On-treatment diastolic blood pressure and prognosis in systolic hypertension.

Authors:  Robert H Fagard; Jan A Staessen; Lutgarde Thijs; Hilde Celis; Christopher J Bulpitt; Peter W de Leeuw; Gastone Leonetti; Jaakko Tuomilehto; Yair Yodfat
Journal:  Arch Intern Med       Date:  2007-09-24

9.  Effect of baseline and changes in systolic blood pressure over time on the effectiveness of valsartan in the Valsartan Heart Failure Trial.

Authors:  Inder S Anand; Thomas S Rector; Michael Kuskowski; Sabu Thomas; N J Holwerda; Jay N Cohn
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

Review 10.  The economic impact of hypertension.

Authors:  William J Elliott
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 May-Jun       Impact factor: 3.738
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.